Inventor · disambiguated record
Andree Amelsberg
Also filed as: AMELSBERG ANDREE
3 granted patents·6 pending applications·19 citations·filing 2002–2017
69Inventor score
Technology areasA61P
Top patents by PatentIndex Score
9 records- 0189US8404697B2Quinazoline derivatives for the treatment of cancer diseasesSOLCA FLAVIO·Filed 2006·Granted Mar 26, 2013·14 cites·2 claims
- 0280US9539258B2Quinazoline derivatives for the treatment of cancer diseasesBOEHRINGER INGELHEIM INT·Filed 2015·Granted Jan 10, 2017·2 cites·5 claims
- 0379US9089571B2Quinazoline derivatives for the treatment of cancer diseasesSOLCA FLAVIO·Filed 2013·Granted Jul 28, 2015·3 cites·3 claims
- 0460US2018360834A1Quinazoline derivatives for the treatment of cancer diseasesBOEHRINGER INGELHEIM INT·Filed 2017·Application pending·0 cites
- 0557US2017112835A1Quinazoline derivatives for the treatment of cancer diseasesBOEHRINGER INGELHEIM INT·Filed 2016·Application pending·0 cites
- 0655US2009306101A1Combination treatment of cancer comprising egfr/her2 inhibitorsSOLCA FLAVIO·Filed 2006·Application pending·0 cites
- 0755US2014199298A1Combination treatment of cancer comprising egfr/her2 inhibitorsSOLCA FLAVIO·Filed 2014·Application pending·0 cites
- 0854US2018086744A1Combination treatment of cancer comprising egfr/her2 inhibitorsBOEHRINGER INGELHEIM INT·Filed 2017·Application pending·0 cites
- 0934US2003103968A1Use of alpha specific antibody BIBH1 in the treatment of cancerFiled 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Andree Amelsberg files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →